Consolidated Statements of Cash Flows (USD $)	6 Months Ended		125 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013
Cash flows from operating activities
Net loss	$ (7,173,912)	$ (4,538,696)	$ (116,785,532)
Adjustments to reconcile net loss to net cash used in operating activities
Stock payable for acquired research and development			112,440
Stock issued for acquired research and development			26,286,589
Stock issued for services			2,061,743
Stock issued for debt in excess of principal			109,070
Amortization of discount on notes payable due to warrants and beneficial conversion feature	1,382,977		8,239,707
Gain on extinguishment of debt			(1,612,440)
Depreciation	167,209	143,851	1,817,367
Amortization of debt financing costs	98,964		681,981
Option and warrant expense	714,871	371,449	16,980,804
Gain on derivative instruments			(1,941,826)
Loss on disposition of fixed assets			513,345
Changes in:
Other current assets	(369,383)	(805,756)	(1,522,436)
Accounts payable - third parties and related parties	635,368	52,336	474,717
Accrued expenses	637,636	(289,167)	1,242,874
Deferred revenue	4,431,063		4,431,063
Other assets	(96,064)		(96,064)
Net cash provided by (used in) operating activities	428,729	(5,065,983)	(59,006,598)
Cash flows from investing activities
Purchase of property & equipment	(22,894)	(473,084)	(2,245,093)
Restricted cash	500,000		(500,000)
Net cash provided by (used in) investing activities	477,106	(473,084)	(2,745,093)
Cash flows from financing activities
Common stock and warrants sold for cash, net of offering costs	3,578,288		53,032,085
Common stock repurchased and canceled			(325)
Proceeds from exercise of warrants and options			1,248,588
Deferred financing and offering costs	(147,847)		(657,339)
Repayments on notes payable	(450,000)		(761,222)
Net cash provided by financing activities	3,530,441		66,779,971
Net change in cash and cash equivalents	4,436,276	(5,539,067)	5,028,280
Cash and cash equivalents at beginning of period	592,004	7,109,215
Cash and cash equivalents at end of period	5,028,280	1,570,148	5,028,280
Cash paid for:
Income tax
Interest	19,128	973	174,237
NON-CASH TRANSACTIONS
Issuance of common stock to Sportan shareholders			147,733
Issuance of common stock for accrued interest			789,287
Issuance of warrants to placement agent			37,453
Conversion of notes payable to common stock	1,000,000		8,709,980
Conversion of accrued liabilities to common stock			197,176
Conversion of accounts payable to note payable			93,364
Discount on convertible notes relating to:
Warrants	195,969		6,170,341
Beneficial conversion feature	141,829		3,444,982
Stock attached to notes			1,287,440
Fair value of derivative instrument			4,680,220
Derivative reclassified to equity			2,349,266
Unpaid additions to property and equipment	108,607	27,450	108,607
Amortization of deferred offering costs to paid-in capital			47,339
Shares issued as deferred offering costs	1,234		150,365
Unpaid additions to deferred financing costs		49,987
Third Parties
Cash flows from financing activities
Proceeds from convertible debt	550,000		13,288,184
Related Parties
Cash flows from financing activities
Proceeds from convertible debt	100,000		730,000
Repayments on notes payable	$ (100,000)		$ (100,000)